Literature DB >> 4875004

The influence of bacteriocins on resistance to infection by gram-negative bacteria. II. Colicin action, transfer of colicinogeny, and transfer of antibiotic resistance in urinary infections.

A I Braude, J S Siemienski.   

Abstract

Dual urinary infections were produced in rats with colicinogenic Escherichia coli CF1, elaborating colicin V in the urine, and colicine-sensitive E. coli 9224 by injecting each organism into the medulla of opposite kidneys. The colicin-sensitive organism was eradicated from the urine of 24.3% of rats and the degree of infection by E. coli 9224 reduced to less than half of the control group. Colicin-resistant mutants of E. coli 9224 were not inhibited in mixed infections with colicin producing E. coli CF1. No evidence of inhibitory activity by colicin V was found in the kidneys. The bladder urine, but not the kidney, was also the site for transfer of colicinogeny between homologous (E. coli) and heterologous (E. coli and Aerobacter aerogenes) species. Episomes controlling colicin V and J + I were transferred within 24 hr after establishing the mixed infection. Since E. coli 9224 was resistant to streptomycin and tetracycline, observations were also made on transmission of multiple drug resistance. Streptomycin and tetracycline resistance was readily transferred to E. coli CF1 within 48 hr in the bladder. These results demonstrate that in urinary infections colicins can kill susceptible bacteria and that bacterial genetic elements are transferred.

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 4875004      PMCID: PMC297336          DOI: 10.1172/JCI105866

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  14 in total

1.  THE INFLUENCE OF BACTERIOCINS ON RESISTANCE TO INFECTION BY GRAM-NEGATIVE BACTERIA. I. THE EFFECT OF COLICIN ON BACTERICIDAL POWER OF BLOOD.

Authors:  A I BRAUDE; J S SIEMIENSKI
Journal:  J Clin Invest       Date:  1965-05       Impact factor: 14.808

2.  Hematogenous pyelonephritis in rats. III. Relationship of bacterial species to the pathogenesis of acute pyeionephritis.

Authors:  A I BRAUDE; A P SHAPIRO; J SIEMIENSKI
Journal:  J Bacteriol       Date:  1959-03       Impact factor: 3.490

3.  Colicinogeny and recombination.

Authors:  S M SMITH; B A STOCKER
Journal:  Br Med Bull       Date:  1962-01       Impact factor: 4.291

4.  Transferable R factors in enteric bacteria causing infection of the genitourinary tract.

Authors:  D H Smith; S E Armour
Journal:  Lancet       Date:  1966-07-02       Impact factor: 79.321

5.  A mechanism of bacterial interference in vitro.

Authors:  J C Ribble
Journal:  J Immunol       Date:  1967-04       Impact factor: 5.422

Review 6.  Transfer of genetic material during bacterial conjugation.

Authors:  J D Gross
Journal:  Br Med Bull       Date:  1965-09       Impact factor: 4.291

7.  Hematogenous pyelonephritis in rats. IV. Relationship of bacterial species to the pathogenesis and sequelae of chronic pyelonephritis.

Authors:  A P SHAPIRO; A I BRAUDE; J SIEMIENSKI
Journal:  J Clin Invest       Date:  1959-07       Impact factor: 14.808

8.  Inhibition of Shigella flexneri by the normal intestinal flora. I. Mechanisms of inhibition by Klebsiella.

Authors:  D J Hentges
Journal:  J Bacteriol       Date:  1967-04       Impact factor: 3.490

9.  In vivo transmission of drug resistance factors between strains of Staphylococcus aureus.

Authors:  R P Novick; S I Morse
Journal:  J Exp Med       Date:  1967-01-01       Impact factor: 14.307

10.  Experimental pyelonephritis. IV. Observations on infections resulting from direct inoculation of bacteria in different zones of the kidney.

Authors:  L R FREEDMAN; P B BEESON
Journal:  Yale J Biol Med       Date:  1958-06
View more
  12 in total

Review 1.  Colicinogeny and related phenomena.

Authors:  K G Hardy
Journal:  Bacteriol Rev       Date:  1975-12

2.  Haemocin, the bacteriocin produced by Haemophilus influenzae: species distribution and role in colonization.

Authors:  J J LiPuma; H Richman; T L Stull
Journal:  Infect Immun       Date:  1990-06       Impact factor: 3.441

3.  Colicins of Escherichia coli strains causing urinary tract infections, sensitivity of these strains towards colicins, and their O-serotypes.

Authors:  V Horák; A Lanc
Journal:  Folia Microbiol (Praha)       Date:  1973       Impact factor: 2.099

4.  Risk of group A meningococcal disease: bacterial interference and cross-reactive bacteria among mucosal flora.

Authors:  G A Filice; P S Hayes; G W Counts; J M Griffiss; D W Fraser
Journal:  J Clin Microbiol       Date:  1985-08       Impact factor: 5.948

5.  Isolation of plasmid deoxyribonucleic acid from two strains of Bacteroides.

Authors:  D G Guiney; C E Davis
Journal:  J Bacteriol       Date:  1975-10       Impact factor: 3.490

6.  Transfer of R-factor mediated aminoglycoside antibiotic resistance in the allantoic cavity of chick embryos.

Authors:  W H Traub; M E Craddock
Journal:  Experientia       Date:  1971-08

7.  Killer factor interference in mixed opportunistic yeast cultures.

Authors:  S Conti; C Cantelli; M Gerloni; P Fisicaro; W Magliani; D Bertolotti; P Mozzoni; D Sullivan; D Coleman; L Polonelli
Journal:  Mycopathologia       Date:  1996       Impact factor: 2.574

8.  Bacteriocin synthesis in uropathogenic and commensal Escherichia coli: colicin E1 is a potential virulence factor.

Authors:  David Smajs; Lenka Micenková; Jan Smarda; Martin Vrba; Alena Sevčíková; Zuzana Vališová; Vladana Woznicová
Journal:  BMC Microbiol       Date:  2010-11-15       Impact factor: 3.605

9.  Distribution of genes encoding the trypsin-dependent lantibiotic ruminococcin A among bacteria isolated from human fecal microbiota.

Authors:  F Marcille; A Gomez; P Joubert; M Ladiré; G Veau; A Clara; F Gavini; A Willems; M Fons
Journal:  Appl Environ Microbiol       Date:  2002-07       Impact factor: 4.792

10.  Modifying effect of colicin on experimental Shigella keratoconjunctivitis.

Authors:  A J Streelman; I S Snyder; E W Six
Journal:  Infect Immun       Date:  1970-07       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.